Ali Rihani
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in
-
- Molecular Biology Techniques and Applications 4
- Cancer therapeutics and mechanisms 3
- RNA Research and Splicing 3
- Ubiquitin and proteasome pathways 3
-
- Neuroblastoma Research and Treatments 9
- Co-authors
- Jo Vandesompele (14 shared papers)Tom Van Maerken (11 shared papers)Frank Speleman (9 shared papers)Anne De Paepe (5 shared papers)Alan Van Goethem (4 shared papers)Nurten Yigit (2 shared papers)Jean‐Christophe Marine (2 shared papers)Steve Lefever (3 shared papers)
In The Last Decade
Ali Rihani
17 papers receiving 542 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 204
- Neurology 179
- Oncology 184
- Molecular Biology 378
- Biotechnology 22
Countries citing papers authored by Ali Rihani
This map shows the geographic impact of Ali Rihani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rihani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rihani more than expected).
Fields of papers citing papers by Ali Rihani
This network shows the impact of papers produced by Ali Rihani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rihani. The network helps show where Ali Rihani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Rihani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 99 | |
| 2 | 2014 | 69 | |
| 3 | 2011 | 61 | |
| 4 | 2009 | 51 | |
| 5 | 2015 | 37 | |
| 6 | 2014 | 37 | |
| 7 | 2013 | 36 | |
| 8 | 2015 | 31 | |
| 9 | 2019 | 30 | |
| 10 | 2011 | 27 | |
| 11 | 2014 | 19 | |
| 12 | 2020 | 14 | |
| 13 | 2013 | 12 | |
| 14 | 2018 | 10 | |
| 15 | 2020 | 10 | |
| 16 | 2014 | 3 | |
| 17 | Selective inhibition of the p53–MDM2 interaction by nutlin drugs: a new therapeutic perspective for neuroblastoma | 2013 | 1 |
| 18 | 2024 | 0 |
About Ali Rihani
Ali Rihani is a scholar working on Molecular Biology, Neurology, Oncology, Cancer Research and Genetics, having authored 18 papers that have together received 547 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (9 papers), Cancer-related Molecular Pathways (8 papers), Molecular Biology Techniques and Applications (4 papers), MicroRNA in disease regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer therapeutics and mechanisms (3 papers), RNA Research and Splicing (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (204 citations), Neurology (179 citations), Oncology (184 citations), Molecular Biology (378 citations) and Biotechnology (22 citations). Ali Rihani has collaborated with scholars based in Belgium, Sweden and Germany. Frequent co-authors include Jo Vandesompele, Tom Van Maerken, Frank Speleman, Anne De Paepe, Alan Van Goethem, Nurten Yigit, Jean‐Christophe Marine, Steve Lefever, Pieter Mestdagh and Gert Van Peer. Their work appears in journals such as Scientific Reports, PLoS ONE, Molecular Cancer Therapeutics, JNCI Journal of the National Cancer Institute and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.